“Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity”. The Journal of Biological Chemistry275 (35): 27258–65. (September 2000). doi:10.1074/jbc.M004850200. PMID10867014.
“Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder”. The New England Journal of Medicine309 (12): 694–8. (September 1983). doi:10.1056/NEJM198309223091203. PMID6604220.
“Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritis”. Journal of Autoimmunity80: 77–84. (June 2017). doi:10.1016/j.jaut.2017.02.008. PMID28291659.
“Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms”. Proteomics6 (11): 3369–80. (June 2006). doi:10.1002/pmic.200500751. PMID16622833.
“Should health-care systems pay for replacement therapy in patients with alpha(1)-antitrypsin deficiency? A critical review and cost-effectiveness analysis”. Chest117 (3): 875–80. (March 2000). doi:10.1378/chest.117.3.875. PMID10713018.
“Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity”. The Journal of Biological Chemistry275 (35): 27258–65. (September 2000). doi:10.1074/jbc.M004850200. PMID10867014.
“Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder”. The New England Journal of Medicine309 (12): 694–8. (September 1983). doi:10.1056/NEJM198309223091203. PMID6604220.
“Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritis”. Journal of Autoimmunity80: 77–84. (June 2017). doi:10.1016/j.jaut.2017.02.008. PMID28291659.
“Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms”. Proteomics6 (11): 3369–80. (June 2006). doi:10.1002/pmic.200500751. PMID16622833.
“Should health-care systems pay for replacement therapy in patients with alpha(1)-antitrypsin deficiency? A critical review and cost-effectiveness analysis”. Chest117 (3): 875–80. (March 2000). doi:10.1378/chest.117.3.875. PMID10713018.